Navigating Alzheimer Disease Treatment Decisions and Timelines

Panelists discuss how initiating Alzheimer therapy demands precise timing and comprehensive coordination among clinical teams. Delays often arise from insurance approvals, diagnostic bottlenecks, and patient readiness.

Panelists discuss how APPs mitigate these delays by guiding patients through administrative steps, scheduling diagnostic imaging, and ensuring follow-up testing is completed promptly. They advocate for transparent communication between all stakeholders to expedite decision-making.

Panelists discuss how proactive management leads to improved patient satisfaction and faster treatment onset, which is especially important with time-sensitive disease-modifying options.